Pharmaceutical Technology Europe, Mar 1, 2010 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology Europe, Mar 1, 2010
Special Feature
Focus on freeze drying digital supplement
Our digital magazine takes a close look at the challenges and trends of lyophilisation, as well as some of the latest innovations.
Challenges and trends in lyophilization
By Octoplus
Pharmaceutical Technology Europe discusses some of the latest challenges and innovations in pharmaceutical lyophilization.
Thermal fingerprinting: a way to optimize lyophilization
By Enric Jo
Freeze drying is widely used in pharmaceuticals to improve the long-term storage stability of labile drugs.
Selecting a freeze dryer
By T.N. Thompson
The most important consideration when choosing a freeze dryer is to ensure the system is fit for both today's applications and future needs.
Manufacturing
Nanotechnology: A lifeline for drying pharma pipelines?
By Jamie C. Oliver , Adriana Vela , Gary Liversidge , Mike Eaton
Pharmaceutical Technology Europe spoke with experts about the developments that have shaped the nanotechnology industry today and the benefits that this technology has to offer the pharmaceutical industry, which remain largely untapped.
Moisture-activated dry granulation: The 'one-pot' process
By Ismat Ullah , Jennifer Wang
Moisture-activated drying granulation is a simple and effective process for particle size enlargement.
Formulation
SMEDDS incorporated polymer matrix: A floating dosage form solution for drugs with poor gastric solubility
By Ashok R. Patel , Pradeep R. Vavia
A new kind of gastro-retentive dosage form for drugs with poor aqueous solubility was developed and evaluated, with the aim of achieving gastro-retention.
Ask the Expert
Enhancing the bioavailability of poorly soluble drugs
By Peter G. Nielsen
Although efforts have been made to improve solubility, many poorly soluble drugs still reach the market. Peter Nielsen discusses new developments in solubilisation technology, which could help those companies seeking to reinvigorate marketed products.
Spotlight
Reinvigorating European R&D innovation
By Faiz Kermani
Could a collaborative approach involving both public and private parties offer a solution to Europe's lack of innovation?
News
News
A round up of some of the news and trends from across the globe.
Editor's Comment
Lyo controversies
By Fedra Pavlou
Last year, a member of the PTE editorial team attended the 2nd Annual Lyophilisation Conference in London (UK).

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here